Percepta: Integrating predictions into early risk/benefit discussions

Description
PhysChem Property and ADME/Tox predictions can inform early risk/benefit assessments for candidate compounds. Used carefully, they help structure discussions among medicinal chemists, DMPK, and formulation teams.

Solution

1. For each candidate, compile a concise prediction summary (from Percepta):
   • logP/logD at relevant pH values.
   • Solubility, pKa.
   • Selected ADME (e.g., clearance, PPB) and toxicity alerts.
2. Present predictions side‑by‑side with any available experimental data.
3. Discuss:
   • How predicted properties align with the target product profile.
   • Key risks (e.g., very low solubility, predicted high clearance, toxicity flags).
4. Use this input to:
   • Decide whether to progress, modify, or deprioritize each candidate.
   • Define which experimental studies to run next (e.g., solubility screen, metabolism assay).
5. Capture decisions explicitly, noting that Percepta outputs are supporting evidence, not sole decision drivers.
6. As project data accumulate, revise how Percepta predictions are weighted for that chemotype.